![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, July 31, 2014 8:09:02 PM
Conversation on twr
$AMBS congrats all. #LymPro V1 interim data (p=0.003) exceeded even my calculations. Take a bow, Dr. Thomas Arendt. Stay tuned for LymPro V2
Expand
Reply
Retweeted
Favorited
jbplens ?@jbplens 50m
@fibonacci1170 source of this information?
Expand
Reply
Retweet
Favorite
Retweeted by nj46nick
fibonacci ?@fibonacci1170 32m
@jbplens $AMBS presented univariate results w/o any stat modeling. Bridge study will compare Alz vs cognitively intact controls. Can top 95% Less
Sentiment: Strong Buy
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM